# Trial Evaluating New Strategy in the Functional Assessment of 3-vessel Disease Using SYNTAXII Score in Patients With PCI

> **NCT02015832** · — · COMPLETED · sponsor: **ECRI bv** · enrollment: 454 (actual)

## Conditions studied

- Heart Diseases
- Cardiovascular Diseases
- 3 Vessel Coronary Artery Disease

## Interventions

- **DEVICE:** Coronary stent
- **RADIATION:** Multi Slice Computed Tomography
- **DEVICE:** instantaneous wave-free ratio
- **DEVICE:** Fractional flow reserve
- **DEVICE:** Intravascular Ultrasound

## Key facts

- **NCT ID:** NCT02015832
- **Lead sponsor:** ECRI bv
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02-06
- **Primary completion:** 2017-03-28
- **Final completion:** 2021-02-04
- **Target enrollment:** 454 (ACTUAL)
- **Last updated:** 2022-07-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02015832

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02015832, "Trial Evaluating New Strategy in the Functional Assessment of 3-vessel Disease Using SYNTAXII Score in Patients With PCI". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02015832. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*